The 52K Estrogen-Regulated Protein Secreted by Breast Cancer Cells and Its Clinical Potential

This publication has 13 references indexed in Scilit:

• RU486, A Progestin and Glucocorticoid Antagonist, Inhibits the Growth of Breast Cancer Cells via the Progesterone Receptor*
  Journal of Clinical Endocrinology & Metabolism, 1985
• IMMUNOHISTOCHEMICAL DETECTION OF THE ESTROGEN-REGULATED 52,000 mol wt PROTEIN IN PRIMARY BREAST CANCERS BUT NOT IN NORMAL BREAST AND UTERUS
  Journal of Clinical Endocrinology & Metabolism, 1984
• Progestin-specific markers in human cell lines: biological and pharmacological applications
  Molecular and Cellular Endocrinology, 1984
• A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47D
  Biochemical and Biophysical Research Communications, 1984
• Antiestrogenic Effect of R5020, a Synthetic Progestin in Human Breast Cancer Cells in Culture*
  Journal of Clinical Endocrinology & Metabolism, 1983
• Estrogens Stimulate Cell Proliferation and Induce Secretory Proteins in a Human Breast Cancer Cell Line (T₄₇D)*
  Journal of Clinical Endocrinology & Metabolism, 1982
• A secreted glycoprotein induced by estrogen in human breast cancer cell lines
  Cell, 1980
• Growth factors from murine sarcoma virus-transformed cells.
  Proceedings of the National Academy of Sciences, 1978
• High resolution two-dimensional electrophoresis of basic as well as acidic proteins
  Cell, 1977
• “Pleiotypic Response”
  Nature New Biology, 1971